Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IFG-H4211 | Human | ActiveMax® Human IFN-gamma / IFNG Protein, Tag Free |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon biosimilar (LG Life Sciences) | Approved | Lg Life Sciences Ltd | Leukemia | Lg Life Sciences Ltd | 1989-01-01 | Leukemia | Details | |||
| Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma) | Approved | Shanghai Chemo Wanbang Biophama Co Ltd | gamma, 伽玛 | Mainland China | Liver Cirrhosis; Arthritis, Rheumatoid | Shanghai Chemo Wanbang Biophama Co Ltd | 1998-01-01 | Liver Cirrhosis; Arthritis, Rheumatoid | Details | |
| Cadi-05 | Cadi-05 | Approved | National Institute Of Allergy And Infectious Diseases (Niaid) | Immuvac, Leprovac, Mycidac-C | India | Carcinoma, Non-Small-Cell Lung; Leprosy | null | 1998-01-01 | Leprosy; Carcinoma, Non-Small-Cell Lung | Details |
| Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | HIV Infections; Spondylitis, Ankylosing; Myelodysplastic Syndromes; Idiopathic Pulmonary Fibrosis; Multiple Myeloma; HIV Wasting Syndrome; Erythema Nodosum; Leprosy, Lepromatous; Carcinoma, Hepatocellular | Details |
| Emapalumab | NI-0501 | Approved | Novimmune | Gamifant | United States | Lymphohistiocytosis, Hemophagocytic | Novimmune Sa | 2018-11-20 | Macrophage Activation Syndrome; Still's Disease, Adult-Onset; Rare Diseases; Arthritis, Juvenile; Immune System Diseases; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine | Phase 2 Clinical | Stony Brook University School Of Medicine, Nyu Langone Medical Center, Nostrum | Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive | Details | |
| Vidofludimus | 4SC-101; SC-12267 | Phase 2 Clinical | 4sc Ag | Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease | Details |
| PP-001 | PP-001 | Phase 2 Clinical | 4sc Ag | Keratoconjunctivitis; Uveitis | Details |
| Recombinant human interferon gamma adenovirus injection | Phase 1 Clinical | Guangzhou Dabo Biological Products Co Ltd | Liver Neoplasms; Nasopharyngeal Neoplasms | Details | |
| OCH-NCNP1 | OCH-NCNP1 | Phase 2 Clinical | Keio University | Multiple Sclerosis; Crohn Disease | Details |
| Tadekinig alfa (AB2 Bio) | Phase 3 Clinical | Ab2 Bio | Macrophage Activation Syndrome; Immune System Diseases | Details | |
| Orismilast | LP-0058; LEO-32731 | Phase 2 Clinical | Leo Pharma Inc | Drug-Related Side Effects and Adverse Reactions; Psoriasis; Dermatitis, Atopic | Details |
| PDS-0101 | PDS-0101B; PDS-0101C; PDS-0101; PDS-0101A; PDS-101 | Phase 2 Clinical | Pds Biotechnology Corporation, Merck Serono | Head and Neck Neoplasms; Papillomavirus Infections; Anal intraepithelial neoplasia; Cervical Intraepithelial Neoplasia; Oropharyngeal Neoplasms; Uterine Cervical Neoplasms | Details |
| SP-002 | SP-002; ASN-002; TG-1042 | Details |
This web search service is supported by Google Inc.
A-Z